Whole exome sequencing in fetuses with isolated increased nuchal translucency: a systematic review and meta-analysis

References

• Drury S, Williams H, Trump N, GOSGene, et al. Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities. Prenat Diagn. 2015; 35(10):1010–1017.
   PubMed Web of Science ®Google Scholar
• Wilson KL, Czerwinski JL, Hoskovec JM, et al. NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy. J Genet Couns. 2013;22(1):4–15.
   PubMed Web of Science ®Google Scholar
• Daum H, Meiner V, Elpeleg O, collaborating authors, et al. Fetal exome sequencing: yield and limitations in a tertiary referral center. Ultrasound Obstet Gynecol. 2019; 53(1):80–86.
   PubMed Web of Science ®Google Scholar
• Carss KJ, Hillman SC, Parthiban V, et al. Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound. Hum Mol Genet. 2014;23(12):3269–3277.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions [Internet]. The Cochrane Collabouration; 2011. Available from: www.cochrane-handbook.org.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 16(7):e1000097.
   Google Scholar
• Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015; 17(5):405–424.
   PubMed Web of Science ®Google Scholar
• Mellis R, Eberhardt RY, Hamilton SJ, PAGE Consortium, et al. Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it? BJOG. 2022;129(1):52–61.
   PubMed Web of Science ®Google Scholar
• Xue S, Yan H, Chen J, et al. Genetic examination for fetuses with increased fetal nuchal translucency by genomic technology. Cytogenet Genome Res. 2020;160(2):57–62.
   PubMed Web of Science ®Google Scholar
• Lord J, McMullan DJ, Eberhardt RY, et al. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet. 2019; 393(10173):747–757.
   PubMed Web of Science ®Google Scholar
• Petrovski S, Aggarwal V, Giordano JL, et al. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet. 2019; 393(10173):758–767.
   PubMed Web of Science ®Google Scholar
• Choy KW, Wang H, Shi M, et al. Prenatal diagnosis of fetuses with increased nuchal translucency by genome sequencing analysis. Front Genet. 2019; 10:761.
   PubMed Web of Science ®Google Scholar
• Yang X, Huang LY, Pan M, et al. Exome sequencing improves genetic diagnosis of fetal increased nuchal translucency. Prenat Diagn. 2020;40(11):1426–1431.
   PubMed Web of Science ®Google Scholar
• Chen M, Chen J, Wang C, et al. Clinical application of medical exome sequencing for prenatal diagnosis of fetal structural anomalies. Eur J Obstet Gynecol Reprod Biol. 2020;251:119–124.
   PubMed Web of Science ®Google Scholar
• Leung GKC, Mak CCY, Fung JLF, et al. Identifying the genetic causes for prenatally diagnosed structural congenital anomalies (SCAs) by whole-exome sequencing (WES). BMC Med Genomics. 2018; 11(1):93.
   PubMedGoogle Scholar
• Sparks TN, Lianoglou BR, Adami RR, et al. University of California fetal–maternal consortium; university of California, san francisco center for maternal–fetal precision medicine. Exome sequencing for prenatal diagnosis in nonimmune hydrops fetalis. N Engl J Med. 2020;383(18):1746–1756.
   PubMed Web of Science ®Google Scholar
• Pauta M, Campos B, Segura-Puimedon M, et al. A. Next-Generation sequencing gene panels and “solo” clinical exome sequencing applied in structurally abnormal fetuses. Fetal Diagn Ther. 2021;48(10):746–756.
   PubMed Web of Science ®Google Scholar
• Pauta M, Martinez-Portilla R, Borrell A. Diagnostic yield of exome sequencing in fetuses with an isolated increased nuchal translucency: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022;59(1):26–32.
   PubMed Web of Science ®Google Scholar
• Lo CK, Mertz D, Loeb M. Newcastle-Ottawa scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014;14:45.
   PubMed Web of Science ®Google Scholar
• Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
   PubMedGoogle Scholar
• Carbone L, Cariati F, Sarno L, et al. Non-Invasive prenatal testing: current perspectives and future challenges. Genes (Basel). 2020;12(1):15.
   PubMed Web of Science ®Google Scholar
• Syngelaki A, Hammami A, Bower S, et al. Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11-13 weeks’ gestation. Ultrasound Obstet Gynecol. 2019;54(4):468–476.
   PubMed Web of Science ®Google Scholar
• D'Amico A, Buca D, Rizzo G, et al. Outcome of fetal echogenic bowel: a systematic review and meta-analysis. Prenat Diagn. 2021;41(4):391–399.
   PubMed Web of Science ®Google Scholar
• Di Mascio D, Buca D, Khalil A, et al. Outcome of isolated fetal talipes: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2019;98(11):1367–1377.
   PubMed Web of Science ®Google Scholar
• Committee on Genetics and the Society for Maternal-Fetal Medicine. Committee opinion no.682: microarrays and Next-Generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology. Obstet Gynecol. 2016;128:e262. Reaffirmed 2019.
   PubMed Web of Science ®Google Scholar
• Rabbani B, Tekin M, Mahdieh N. The promise of whole-exome sequencing in medical genetics. J Hum Genet. 2014;59(1):5–15.
   PubMed Web of Science ®Google Scholar
• Hu T, Tian T, Zhang Z, et al. Prenatal chromosomal microarray analysis in 2466 fetuses with ultrasonographic soft markers: a prospective cohort study. Am J Obstet Gynecol. 2021;224(5):516.e1–516.e16.
   PubMed Web of Science ®Google Scholar
• Shaffer LG, Rosenfeld JA, Dabell MP, et al. Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound. Prenat Diagn. 2012;32(10):986–995.
   PubMed Web of Science ®Google Scholar